Language:
Instant News and Commentaries
HSI Closes Up 41 pts as Kingsoft Series Spike; XPENG Drops Post-results
20 Nov 2024 16:34
The HSI added 41 points or 0.2% to close at 19,705. The HSCEI inched up 6 points or 0.1% to close at 7,090. The HSTECH picked up 18 points or 0.4% to close at 4,413. The total market turnover for the day amounted to $114.671 billion.

BABA-W (09988.HK) issued US$2.65 billion and RMB17 billion senior unsecured notes for debt repayment and share buybacks. The stock slid 0.6% to $84.75. WB-SW (09898.HK)'s 1Q24-3Q24 net profit inclined 13%, and its share price swelled 7.9%. KINGSOFT (03888.HK) rallied 9.4% as its 3Q24 net profit surged 13.5x, while its same series KINGSOFT CLOUD (03896.HK) soared 27% as its 3Q24 loss widened to RMB1.057 billion.

Pharma were popular. UBS wrote in its report that it was optimistic about the diabetes drug prospects of INNOVENT BIO (01801.HK). INNOVENT BIO escalated 8.1%, while AKESO (09926.HK) spiked nearly 10%. HANSOH PHARMA (03692.HK), BEIGENE (06160.HK) and SINO BIOPHARM (01177.HK) leaped 3.4-4.2%.

For car makers, XPENG-W (09868.HK) shed 3.1% as it narrowed its 3Q24 non-GAAP net loss to RMB1.53 billion and planned to launch at least four new models next year. GEELY AUTO (00175.HK) cascaded 2.1%, while GWMOTOR (02333.HK) and NIO-SW (09866.HK) faded 3.7%.
~



AAStocks Financial News
Web Site: www.aastocks.com
SG Top Picks
Stock & Type Code Strike(Call Level) Last Effective Gearing
GEELY (C) 28860 19.52 (-) N/A N/A
HKEX (C) 28582 413 (-) N/A N/A
HKEX (C) 28376 385 (-) N/A N/A
HKEX (P) 28006 234 (-) N/A N/A
TENCT (C) 27893 560.5 (-) N/A N/A
TENCT (C) 26379 500.5 (-) N/A N/A
TENCT (P) 28485 363.43 (-) N/A N/A
KUASO (C) 22772 60.05 (-) N/A N/A
XIAOMI (C) 28952 37.04 (-) N/A N/A
XIAOMI (P) 28288 19.98 (-) N/A N/A
MTUAN (C) 28285 275.2 (-) N/A N/A
MTUAN (C) 28594 242 (-) N/A N/A
MTUAN (P) 28005 150 (-) N/A N/A
BAIDU (C) 25923 105.1 (-) N/A N/A
ALIBA (C) 25433 99 (-) N/A N/A
ALIBA (C) 25825 89.04 (-) N/A N/A

 

Information Provided by AAStocks Financial News [Disclaimer]
Subscribe Newsletter
Get the latest news from us by inputing your email address here.
(Please read our Privacy Policy)